Combination therapy shows improved response in some
SGN-CD33A demonstrates encouraging antileukemic activity
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement